Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
cancer
deals
life sciences
national blog main
new york blog main
raleigh-durham blog main
san diego blog main
2
×
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
10x genomics
abbvie
akouos
allergan
alnylam pharmaceuticals
amag pharmaceuticals
amunix
anirvan ghosh
astellas pharma
astrazeneca
becton dickinson
biogen
bluerock therapeutics
boston blog main
boulder/denver blog main
boulder/denver top stories
cancer diagnostics
cancer immunotherapy
cerovene
clinical trials
covid-19
crispr
deerfield management
detroit blog main
detroit top stories
diagnostic device
durvalumab
editas medicine
What
deal
2
×
help
2
×
acquisitions
adding
aims
announced
bio
ceo
collabs
company
covid
daniel
decisions
diagnostic
diagnostics
expand
fold
gilead
gilead’s
introduce
ipo
make
medicines
month
nanostring
o’day
physicians
plans
reach
roundup
sciences
technology
tests
transformative
treatment
veracyte
years
Language
unset
Current search:
deal
×
help
×
" san diego blog main "
×
@xconomy.com
4 years ago
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More
@xconomy.com
4 years ago
Veracyte Aims to Expand Diagnostics Reach With $50M NanoString Deal
